Impaired development of bone mineral density during chemotherapy: A prospective analysis of 46 children newly diagnosed with cancer

Journal of Bone and Mineral Research

Volumn 14, Issue 12, 1999, Pages 2002-2009

  Arikoski, Pekka ^a   Komulainen, Jorma ^a   Riikonen, Pekka ^a   Parviainen, Markku ^a   Jurvelin, Jukka S ^a   Voutilainen, Raimo ^a   Kröger, Heikki ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN DERIVATIVE; COLLAGEN TYPE 1; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; OSTEOCALCIN; VINCRISTINE;

ADOLESCENT; ARTICLE; BONE DENSITY; BONE MASS; BONE TURNOVER; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LEUKEMIA; LYMPHOMA; MALE; OSTEOPENIA; OSTEOPOROSIS; SOLID TUMOR;

EID: 0033389209     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.12.2002     Document Type: Article

References (45)

1. Halton JM, Atkinson SA, Fraher L, Webber CE, Cockshott WP, Tam C, Barr RD 1995 Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr 126:557-564.
2. Halton JM, Atkinson SA, Fraher L, Webber C, Gill GJ, Dawson S, Barr RD 1996 Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res 11:1774-1783.
3. Atkinson SA, Fraher L, Gundberg CM, Andrew M, Pai M, Barr RD 1989 Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. J Pediatr 114:793-800.
4. Nussey S, Hyer S, Brada M, Leiper A 1994 Bone mineralization after treatment of growth hormone deficiency in survivors of childhood malignancy. Acta Paediatr Suppl 399:9-14.
5. D'Angelo P, Conter V, Di Chiara G, Rizzari C, Barigozzi P 1993 Severe osteoporosis and multiple vertebral collapses in a child during treatment for B-ALL. Acta Haematol 89:38-42.
6. Gilsanz V, Carlson ME, Roe TF, Ortega JA 1990 Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. J Pediatr 117:238-244.
7. Henderson RC, Madsen CD, Davis C, Gold SH 1996 Bone density in survivors of childhood malignancies. J Pediatr Hematol Oncol 18:367-372.
8. Nysom K, Holm K, Michaelsen KF, Hertz H, Müller J, Mølgaard C 1998 Bone mass after treatment for acute lymphoblastic leukemia in childhood. J Clin Oncol 16:3752-3760.
9. Arikoski P, Komulainen J, Voutilainen R, Riikonen P, Parviainen M, Tapanainen P, Knip M, Kroger H 1998 Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 20:234-240.
10. Arikoski P, Komulainen J, Riikonen P, Jurvelin J, Voutilainen R, Kroger H 1999 Reduced bone density at completion of chemotherapy for a malignancy. Arch Dis Child 80:143-148.
11. Sorva R, Kivivuori S-M, Turpeinen M, Marttinen E, Risteli J, Risteli L, Sorva A, Siimes MA 1997 Very low rate of type I collagen synthesis and degradation in newly diagnosed children with acute lymphoblastic leukemia. Bone 20:139-143.
12. Crofton PM, Ahmed SF, Wade JC, Stephen MW, Elmlinger MW, Ranke MB, Kelnar CJH, Walace WHB 1998 Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab 83:3121-3129.
13. Henderson RC, Madsen CD, Davis C, Gold SH 1998 Longitudinal evaluation of bone mineral density in children receiving chemotherapy. J Pediatr Hematol Oncol 20:322-326.
14. Schwartz AM, Leonidas JC 1984 Methotrexate osteopathy. Skeletal Radiol 11:13-16.
15. Neuhauser EBD, Wittenborg MH, Berman CZ, Cohen J 1952 Irradiation effects of roentgen therapy on the growing spine. Radiology 59:637-650.
16. Shalet SM 1989 Endocrine consequences of treatment of malignant disease. Arch Dis Child 64:1635-1641.
17. Leiper A 1990 Management of growth failure in the treatment of malignant disease. Pediatr Haematol Oncol 7:365-371.
18. Lie SO, Gustafsson G 1992 Progress in the treatment of childhood leukemias. Ann Med 24:319-323.
19. Lie S, Jonmundsson G, Mellander L, Siimes MA, Yssing M, Gustafsson G on behalf of NOPHO 1996 A population based study of 272 children with acute myeloid leukemia treated on two consecutive protocols with different intensity: Best outcome in girls, infants and in children with Down's syndrome. Br J Hematol 94:82-88.
20. Hunger SP, Link MP, Donaldsson AA 1994 ABVD/MOPP and low dose involved field radiotherapy in pediatric Hodgkin's disease: The Stanford experience. J Clin Oncol 12:2160-2166.
21. Geyer JR, Zelter PM, Boyett JM, Rorke LB, Stanley P, Albright AL, Wisoff SH, Milstein JM, Allen JC, Finley JC 1994 Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the childrens' cancer group. J Clin Oncol 112:1607-1615.
22. Reiter A, Schrappe M, Parwaresch R, Henze G, Müller-Weihrich S, Sauter S, Sykora K-W, Ludwig W-D. Gadner H. Riehm H 1995 Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage - A report of the Berlin-Frankfurt-Münster Group. J Clin Oncol 13:359-372.
23. Bacci G, Picci P, Ruggieri P. Mercuri M, Avella M, Cappana R, Brach-Del-Prever A, Mancini A, Gherlinzoni F, Padovani G 1990 Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities: The Instituto Rizzoli's experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intra arterial cisplatin. Cancer 65:2539-2553.
24. Meyer WH, Pratt CB, Thompson EI 1991 Ifosfamide/ etoposide (lfos/VP-16) in patients with previously untreated Ewing's sarcoma (ES) or primitive neuroectodermal tumors (PPNET). Proc Am Soc Clin Oncol 10:307.
25. Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrman J, Heyn R 1995 The third intergroup rhabdomyosarcoma study. J Clin Oncol 3:610-630.
26. Green DM, Breslow NE, Evans I, Moksness J, Finkelstein JZ, Evans AE, D'Angio GJ 1994 Effect of dose intensity of chemotherapy on the hematological toxicity of the treatment of Wilms tumor: A report from the National Wilms Tumor Study. Am J Pediatr Hematol Oncol 16:207.
27. Kroger H, Kotaniemi A, Kroger L, Alhava E 1993 Development of bone mass and bone density of the spine and femoral neck - A prospective study of 65 children and adolescents. Bone Miner 23:171-182.
28. Kroger H, Kotaniemi A, Vainio P, Alhava E 1992 Bone densitometry of the spine and femur in children by dual-energy X-ray absorptiometry. Bone Miner 17:75-85.
29. Tanner JM 1962 Growth at Adolescence, 2nd Ed. Blackwell Scientific Publications, Oxford, U.K.
30. Crofton P, Wade J, Taylor MV, Holland C 1997 Serum concentrations of carboxy-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxy-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren. Clin Chem 43:1577-1581.
31. Rauch F, Stabrey A, Schönau E 1996 Appendix: Reference values in pediatric osteology. In: Schönau E (ed.) Pediatric Osteology: New Developments in Diagnostics and Therapy. Elsevier Science BV, Amsterdam, The Netherlands, pp. 295-300.
32. Moreira-Andrés Canizo FJ, Papapietro K, Rejas J, Hawkins F 1995 Comparison between spinal and radial bone mineral density in children measured by X-ray absorptiometry. J Pediatr Endocrinol Metab 8:35-41.
33. Eastell R 1995 Management of corticosteroid-induced osteoporosis. J Intern Med 237:439-447.
34. Minaire P 1989 Immobilization osteoporosis: A review. Clin Rheumatol 8 (Suppl 2):95-103.
35. Brunner R, Doderlein L 1994 Pathological fractures in patients with cerebral palsy. J Pediatr Orthop B 4:232-238.
36. Calvo M, Eyre D, Gundberg C 1996 Molecular basis and clinical application of biological markers of hone turnover. Endocr Rev 17:333-368.
37. Risteli L, Risteli J 1993 Biochemical markers of bone metabolism. Ann Med 25:385-393.
38. Crofton PM 1998 New aspects of biochemical markers of bone turnover in paediatrics. In: Schönau E, Matkovic V (eds.) Pediatric Osteology: Prevention of Osteoporosis - A Paediatric Task? Elsevier Science BV, Amsterdam, The Netherlands, pp. 3-14.
39. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR 1986 Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 319:516-518.
40. Atkinson S, Halton J, Bradley C, Wu Barr R 1998 Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: Influence of disease, drugs and nutrition. Int J Cancer Suppl 11:35-39.
41. Anast CS, Winnacker JL, Forte LR, Burns TW 1976 Impaired release of parathyroid hormone in magnesium deficiency. J Clin Endocrinol Metab 42:707-715.
42. Merritt RJ, Kalsch M, Roux LD, Ashley-Mills J, Siegel SS 1985 Significance of hypoalbuminemia in pediatric oncology patients-malnutrition or infection? J Parenter Enteral Nutr 3:303-306.
43. Saggese G, Baroncelli G, Barsanti S 1996 Bone mineral density during growth hormone therapy. In: Schönau E (ed.) Pediatric Osteology: New Developments in Diagnostics and Therapy. Elsevier Science BV, Amsterdam, The Netherlands, pp. 109-113.
44. Ruiz J, Mandel C, Garabedian M 1995 Influence of spontaneous calcium intake and physical exercise on the vertebral and femoral bone mineral density of children and adolescents. J Bone Miner Res 10:675-682.
45. Johnston C, Miller J, Slemenda C 1992 Calcium supplementation and increase in bone mineral density in children. N Engl J Med 327:82-87.